115 related articles for article (PubMed ID: 35420322)
1. Molecular docking unveils the potential of andrographolide derivatives against COVID-19: an in silico approach.
Veerasamy R; Karunakaran R
J Genet Eng Biotechnol; 2022 Apr; 20(1):58. PubMed ID: 35420322
[TBL] [Abstract][Full Text] [Related]
2. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
[TBL] [Abstract][Full Text] [Related]
3. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
[TBL] [Abstract][Full Text] [Related]
4.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19.
Arumugam S; Vadivel K; Dhaked DK; Prasanna VS; Yellurkar ML; Das P; Manoharan R; Thomas AJ; Singh L; Singh S; Velayutham R
Homeopathy; 2024 Feb; 113(1):16-24. PubMed ID: 37673083
[TBL] [Abstract][Full Text] [Related]
6. In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases.
Chowdhury T; Roymahapatra G; Mandal SM
Infect Disord Drug Targets; 2021; 21(4):608-618. PubMed ID: 32718300
[TBL] [Abstract][Full Text] [Related]
7. Potential of Marine Terpenoids against SARS-CoV-2: An
Sahoo A; Fuloria S; Swain SS; Panda SK; Sekar M; Subramaniyan V; Panda M; Jena AK; Sathasivam KV; Fuloria NK
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829734
[TBL] [Abstract][Full Text] [Related]
8. Silybin B and Cianidanol Inhibit M
Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
[TBL] [Abstract][Full Text] [Related]
9.
Teli DM; Shah MB; Chhabria MT
Front Mol Biosci; 2020; 7():599079. PubMed ID: 33542917
[TBL] [Abstract][Full Text] [Related]
10. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
11.
Bhargavi S; Madhan Shankar SR; Jemmy CH
J Biomol Struct Dyn; 2023 May; 41(8):3265-3280. PubMed ID: 35257637
[TBL] [Abstract][Full Text] [Related]
12. Metabologenomics approach to the discovery of novel compounds from
Melinda YN; Widada J; Wahyuningsih TD; Febriansah R; Damayanti E; Mustofa M
Heliyon; 2021 Nov; 7(11):e08308. PubMed ID: 34746476
[TBL] [Abstract][Full Text] [Related]
13. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
14. The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19.
Anwar F; Altayb HN; Al-Abbasi FA; Kumar V; Kamal MA
Curr Pharm Des; 2021; 27(9):1202-1210. PubMed ID: 33550966
[TBL] [Abstract][Full Text] [Related]
15.
Mani M; Vellusamy M; Rathinavel T; Vadivel P; Dauchez M; Khan R; Aroulmoji V
J Biomol Struct Dyn; 2024 Mar; ():1-15. PubMed ID: 38533826
[TBL] [Abstract][Full Text] [Related]
16.
Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
[TBL] [Abstract][Full Text] [Related]
17. Working goal of Brazilein sappan wood as a candidate for SARS-coV-2 antivirus drug against spike (S) glycoprotein, papain-like proteinase, and main protease:
Kurniawan E; Krihariyani D
J Adv Pharm Technol Res; 2021; 12(3):298-304. PubMed ID: 34345611
[TBL] [Abstract][Full Text] [Related]
18. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
19. Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective.
Sonousi A; Mahran HA; Ibrahim IM; Ibrahim MN; Elfiky AA; Elshemey WM
Pharmacol Rep; 2021 Dec; 73(6):1754-1764. PubMed ID: 34165771
[TBL] [Abstract][Full Text] [Related]
20.
Vijayakumar M; Janani B; Kannappan P; Renganathan S; Al-Ghamdi S; Alsaidan M; Abdelaziz MA; Peer Mohideen A; Shahid M; Ramesh T
Saudi J Biol Sci; 2022 Jan; 29(1):18-29. PubMed ID: 34729030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
